Jama : Journal of the American Medical Association, ISSN 0098-7484, 2015, Volume 313, Issue 19, pp. 1924 - 1938
IMPORTANCE: Cerebral amyloid-beta aggregation is an early pathological event in Alzheimer disease (AD), starting decades before dementia onset. Estimates of...
OLDER PERSONS | POPULATION | MEDICINE, GENERAL & INTERNAL | CEREBROSPINAL-FLUID BIOMARKERS | COHORT | MILD COGNITIVE IMPAIRMENT | DIAGNOSTIC-CRITERIA | BETA-AMYLOIDOSIS | ASSOCIATION | PIB PET | ALZHEIMER-DISEASE PATHOLOGY | Apolipoprotein E4 - genetics | Dementia - pathology | Prevalence | Age Factors | Humans | Middle Aged | Risk Factors | Biomarkers - analysis | Genotype | Male | Positron-Emission Tomography | Cognitive Dysfunction - pathology | Cerebrospinal Fluid - chemistry | Aged, 80 and over | Amyloid beta-Peptides - analysis | Brain - pathology | Adult | Female | Aged | Usage | Analysis | Amyloidosis | Cognition | Research | Biological markers | Risk factors | Meta-analysis | Prevalence studies (Epidemiology) | Pathology | Medical research | Neurological disorders | Dementia | Brain | Neurosciences | pathology | Biological Markers | 80 and over | genetics | Amyloid beta-Peptides | Neurovetenskaper | chemistry | Apolipoprotein E4 | Cerebrospinal Fluid | analysis | Mild Cognitive Impairment
OLDER PERSONS | POPULATION | MEDICINE, GENERAL & INTERNAL | CEREBROSPINAL-FLUID BIOMARKERS | COHORT | MILD COGNITIVE IMPAIRMENT | DIAGNOSTIC-CRITERIA | BETA-AMYLOIDOSIS | ASSOCIATION | PIB PET | ALZHEIMER-DISEASE PATHOLOGY | Apolipoprotein E4 - genetics | Dementia - pathology | Prevalence | Age Factors | Humans | Middle Aged | Risk Factors | Biomarkers - analysis | Genotype | Male | Positron-Emission Tomography | Cognitive Dysfunction - pathology | Cerebrospinal Fluid - chemistry | Aged, 80 and over | Amyloid beta-Peptides - analysis | Brain - pathology | Adult | Female | Aged | Usage | Analysis | Amyloidosis | Cognition | Research | Biological markers | Risk factors | Meta-analysis | Prevalence studies (Epidemiology) | Pathology | Medical research | Neurological disorders | Dementia | Brain | Neurosciences | pathology | Biological Markers | 80 and over | genetics | Amyloid beta-Peptides | Neurovetenskaper | chemistry | Apolipoprotein E4 | Cerebrospinal Fluid | analysis | Mild Cognitive Impairment
Journal Article
JAMA Psychiatry, ISSN 2168-622X, 2018, Volume 75, Issue 1, pp. 84 - 95
Importance: Cerebral amyloid-beta aggregation is an early event in Alzheimer disease (AD). Understanding the association between amyloid aggregation and...
INDIVIDUALS | LIFE-SPAN | MEMORY PERFORMANCE | METAANALYSIS | PSYCHIATRY | PRECLINICAL ALZHEIMERS-DISEASE | APOE | BURDEN | DECLINE | AGE | IMPAIRMENT | Alzheimer Disease - physiopathology | Cognition Disorders - physiopathology | Cross-Sectional Studies | Brain - physiopathology | Humans | Middle Aged | Memory, Episodic | Male | Reference Values | Mental Status and Dementia Tests | Positron-Emission Tomography | Cognitive Dysfunction - physiopathology | Alzheimer Disease - diagnosis | Cognition Disorders - diagnosis | Amyloid beta-Peptides - cerebrospinal fluid | Cognitive Dysfunction - psychology | Female | Aged | Cognitive Dysfunction - diagnosis | Alzheimer Disease - psychology | Cognition Disorders - psychology | Online First | Original Investigation | Research | Clinical Medicine | No dementia | Medical and Health Sciences | Medicin och hälsovetenskap | amyloid-β | cognitive functioning | Klinisk medicin | Geriatrik | Geriatrics
INDIVIDUALS | LIFE-SPAN | MEMORY PERFORMANCE | METAANALYSIS | PSYCHIATRY | PRECLINICAL ALZHEIMERS-DISEASE | APOE | BURDEN | DECLINE | AGE | IMPAIRMENT | Alzheimer Disease - physiopathology | Cognition Disorders - physiopathology | Cross-Sectional Studies | Brain - physiopathology | Humans | Middle Aged | Memory, Episodic | Male | Reference Values | Mental Status and Dementia Tests | Positron-Emission Tomography | Cognitive Dysfunction - physiopathology | Alzheimer Disease - diagnosis | Cognition Disorders - diagnosis | Amyloid beta-Peptides - cerebrospinal fluid | Cognitive Dysfunction - psychology | Female | Aged | Cognitive Dysfunction - diagnosis | Alzheimer Disease - psychology | Cognition Disorders - psychology | Online First | Original Investigation | Research | Clinical Medicine | No dementia | Medical and Health Sciences | Medicin och hälsovetenskap | amyloid-β | cognitive functioning | Klinisk medicin | Geriatrik | Geriatrics
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 2013, Volume 9, Issue 4, pp. 414 - 421
Abstract Background [11 C]Pittsburgh compound B ([11 C]PIB) and [18 F]-2-fluoro-2-deoxy-D-glucose ([18 F]FDG) PET measure fibrillar amyloid-β load and glucose...
Neurology | [11C]PIB | [18F]FDG | MCI | Alzheimer’s disease | FTD | Lewy body dementia | SMC | PET | Memory clinic | Alzheimer's disease | FDG-PET | CEREBRAL GLUCOSE-METABOLISM | AMYLOID DEPOSITION | RESEARCH CRITERIA | [C-11]PIB | FRONTOTEMPORAL DEMENTIA | [F-18]FDG | MILD COGNITIVE IMPAIRMENT | ALZHEIMERS ASSOCIATION WORKGROUPS | PITTSBURGH COMPOUND-B | CLINICAL NEUROLOGY | NATIONAL INSTITUTE | POSITRON-EMISSION-TOMOGRAPHY | Brain - diagnostic imaging | Prospective Studies | Dementia - psychology | Follow-Up Studies | Lewy Body Disease - diagnosis | Aniline Compounds | Humans | Middle Aged | Dementia - diagnosis | Male | Molecular Imaging | Frontotemporal Dementia - psychology | Lewy Body Disease - psychology | Positron-Emission Tomography | Alzheimer Disease - diagnosis | Sensitivity and Specificity | Thiazoles | Female | France | Radiopharmaceuticals | Alzheimer Disease - psychology | Dementia - diagnostic imaging | Memory Disorders - diagnostic imaging | Frontotemporal Dementia - diagnostic imaging | Diagnosis, Differential | Outpatient Clinics, Hospital - statistics & numerical data | Treatment Outcome | Frontotemporal Dementia - diagnosis | Lewy Body Disease - diagnostic imaging | Disease Progression | Memory Disorders - etiology | Fluorodeoxyglucose F18 | Aged | Alzheimer Disease - diagnostic imaging | Fluorine Radioisotopes | Early Diagnosis | Carbon Radioisotopes | Glucose metabolism | Neurosciences | Amyloid beta-protein | Diagnosis | Glucose | Dextrose
Neurology | [11C]PIB | [18F]FDG | MCI | Alzheimer’s disease | FTD | Lewy body dementia | SMC | PET | Memory clinic | Alzheimer's disease | FDG-PET | CEREBRAL GLUCOSE-METABOLISM | AMYLOID DEPOSITION | RESEARCH CRITERIA | [C-11]PIB | FRONTOTEMPORAL DEMENTIA | [F-18]FDG | MILD COGNITIVE IMPAIRMENT | ALZHEIMERS ASSOCIATION WORKGROUPS | PITTSBURGH COMPOUND-B | CLINICAL NEUROLOGY | NATIONAL INSTITUTE | POSITRON-EMISSION-TOMOGRAPHY | Brain - diagnostic imaging | Prospective Studies | Dementia - psychology | Follow-Up Studies | Lewy Body Disease - diagnosis | Aniline Compounds | Humans | Middle Aged | Dementia - diagnosis | Male | Molecular Imaging | Frontotemporal Dementia - psychology | Lewy Body Disease - psychology | Positron-Emission Tomography | Alzheimer Disease - diagnosis | Sensitivity and Specificity | Thiazoles | Female | France | Radiopharmaceuticals | Alzheimer Disease - psychology | Dementia - diagnostic imaging | Memory Disorders - diagnostic imaging | Frontotemporal Dementia - diagnostic imaging | Diagnosis, Differential | Outpatient Clinics, Hospital - statistics & numerical data | Treatment Outcome | Frontotemporal Dementia - diagnosis | Lewy Body Disease - diagnostic imaging | Disease Progression | Memory Disorders - etiology | Fluorodeoxyglucose F18 | Aged | Alzheimer Disease - diagnostic imaging | Fluorine Radioisotopes | Early Diagnosis | Carbon Radioisotopes | Glucose metabolism | Neurosciences | Amyloid beta-protein | Diagnosis | Glucose | Dextrose
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2014, Volume 39, Issue 1, pp. 89 - 101
Journal Article
Journal of Alzheimer'S Disease, ISSN 1387-2877, 2014, Volume 39, Issue 1, pp. 89 - 101
Amyloid-beta (Abeta) deposition, one of the main hallmarks of Alzheimer's disease (AD), has been linked to glutamatergic dysfunction, i.e., increased...
TgSwDI mice | autoradiography | glycine | amino acid analysis | amyloid-β | vesicular glutamate transporter 1 | western blot | Alzheimer's disease | glutamate | ALZHEIMERS-DISEASE | COGNITIVE IMPAIRMENT | AMYLOID-BETA-PROTEIN | NEUROSCIENCES | PREFRONTAL CORTEX | amyloid-beta | VESICULAR GLUTAMATE TRANSPORTERS | MOUSE MODEL | EARLY-ONSET | CULTURED ASTROCYTES | PRECURSOR PROTEIN | TRANSGENIC MICE | Glycine - metabolism | Vesicular Glutamate Transport Protein 1 - metabolism | Cerebellum - metabolism | Mice, Inbred C57BL | Receptors, N-Methyl-D-Aspartate - metabolism | Mice, Transgenic | Cerebral Cortex - metabolism | Disease Progression | Autoradiography | Hippocampus - metabolism | Animals | Alzheimer Disease - metabolism | Amyloid beta-Peptides - metabolism | Amyloid beta-Protein Precursor - metabolism | Glutamic Acid - metabolism | Mice | Aging - metabolism | Disease Models, Animal
TgSwDI mice | autoradiography | glycine | amino acid analysis | amyloid-β | vesicular glutamate transporter 1 | western blot | Alzheimer's disease | glutamate | ALZHEIMERS-DISEASE | COGNITIVE IMPAIRMENT | AMYLOID-BETA-PROTEIN | NEUROSCIENCES | PREFRONTAL CORTEX | amyloid-beta | VESICULAR GLUTAMATE TRANSPORTERS | MOUSE MODEL | EARLY-ONSET | CULTURED ASTROCYTES | PRECURSOR PROTEIN | TRANSGENIC MICE | Glycine - metabolism | Vesicular Glutamate Transport Protein 1 - metabolism | Cerebellum - metabolism | Mice, Inbred C57BL | Receptors, N-Methyl-D-Aspartate - metabolism | Mice, Transgenic | Cerebral Cortex - metabolism | Disease Progression | Autoradiography | Hippocampus - metabolism | Animals | Alzheimer Disease - metabolism | Amyloid beta-Peptides - metabolism | Amyloid beta-Protein Precursor - metabolism | Glutamic Acid - metabolism | Mice | Aging - metabolism | Disease Models, Animal
Journal Article
Alzheimer's & Dementia, ISSN 1552-5260, 2018, Volume 14, pp. 913 - 924
INTRODUCTION: Apolipoprotein E (APOE) epsilon4 is the major genetic risk factor for Alzheimer's disease (AD), but its prevalence is unclear because earlier...
Journal Article
Parkinsonism and Related Disorders, ISSN 1353-8020, 2008, Volume 14, pp. S10 - S10
Journal Article
Alzheimer's Research & Therapy, ISSN 1758-9193, 2013, Volume 5, Issue 4, pp. 36 - 36
The possibility to map amyloid-beta, the Alzheimer's disease hallmark protein, in vivo opens the application for amyloid imaging in clinical trials with...
Journal Article
The Journal of Nuclear Medicine (1978), ISSN 0161-5505, 2012, Volume 53, Issue 1, pp. 154 - 163
Dopamine Plasma Membrane Transport Proteins - metabolism | Tomography, Emission-Computed, Single-Photon - methods | Humans | Documentation | Image Interpretation, Computer-Assisted | Tomography, Emission-Computed, Single-Photon - standards | Contraindications | Pregnancy | Societies, Medical | Female | Nortropanes | Nuclear Medicine | Research Design
Journal Article
EJNMMI Research, ISSN 2191-219X, 2013, Volume 3, Issue 1, pp. 1 - 10
The aim of this randomised pilot study was to investigate the haemodynamic effects measured by oxygen-15 positron emission tomography (PET) of interventional...
Medicine & Public Health | Carotid artery diseases | Orthopedics | Other cerebrovascular disease/stroke | Oncology | Haemodynamics | Nuclear Medicine | Imaging / Radiology | Cardiology | PET | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Medicine & Public Health | Carotid artery diseases | Orthopedics | Other cerebrovascular disease/stroke | Oncology | Haemodynamics | Nuclear Medicine | Imaging / Radiology | Cardiology | PET | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Neuroimage, ISSN 1053-8119, 2008, Volume 41, pp. T128 - T128
Methods As part of an ongoing study, 5 healthy controls [age range 22-43 years, 3 males] without any psychiatric or neurological condition, and no history of...
Medical research | Sleep deprivation
Medical research | Sleep deprivation
Journal Article
NeuroImage: Clinical, ISSN 2213-1582, 2015, Volume 7, Issue C, pp. 34 - 42
An emerging issue in neuroimaging is to assess the diagnostic reliability of PET and its application in clinical practice. We aimed at assessing the accuracy...
FDG-PET | MCI | Discriminant analysis | EADC | Volume of interest | DEMENTIA | MILD COGNITIVE IMPAIRMENT | NEUROIMAGING | NATIONAL INSTITUTE | POSITRON-EMISSION-TOMOGRAPHY | GLUCOSE-METABOLISM | AUTOMATED-ANALYSIS | RECOMMENDATIONS | DIAGNOSTIC GUIDELINES | ASSOCIATION WORKGROUPS | Brain - diagnostic imaging | Humans | Image Interpretation, Computer-Assisted - methods | Middle Aged | Male | Positron-Emission Tomography | Disease Progression | Aged, 80 and over | Female | Fluorodeoxyglucose F18 | Aged | Alzheimer Disease - diagnostic imaging | Cognitive Dysfunction - diagnostic imaging | Radiopharmaceuticals
FDG-PET | MCI | Discriminant analysis | EADC | Volume of interest | DEMENTIA | MILD COGNITIVE IMPAIRMENT | NEUROIMAGING | NATIONAL INSTITUTE | POSITRON-EMISSION-TOMOGRAPHY | GLUCOSE-METABOLISM | AUTOMATED-ANALYSIS | RECOMMENDATIONS | DIAGNOSTIC GUIDELINES | ASSOCIATION WORKGROUPS | Brain - diagnostic imaging | Humans | Image Interpretation, Computer-Assisted - methods | Middle Aged | Male | Positron-Emission Tomography | Disease Progression | Aged, 80 and over | Female | Fluorodeoxyglucose F18 | Aged | Alzheimer Disease - diagnostic imaging | Cognitive Dysfunction - diagnostic imaging | Radiopharmaceuticals
Journal Article
European Neuropsychopharmacology, ISSN 0924-977X, 2015, Volume 25, pp. S302 - S302
Journal Article
European Neuropsychopharmacology, ISSN 0924-977X, 2013, Volume 23, pp. S93 - S94
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.